Money

Bessent Asserts 'Permanent' Tariff Structure Regardless of Supreme Court Ruling

U.S. Treasury Secretary Scott Bessent recently conveyed strong assurance regarding the administration's commitment to upholding its tariff regulations, irrespective of the Supreme Court's impending decision on their legality. His statements underscore a firm belief in the executive branch's capacity to navigate legal challenges and sustain its trade policies.

During a discussion at The New York Times DealBook Summit, Bessent articulated his confidence, emphasizing that various provisions within the 1962 Trade Act grant the president extensive authority over import duties. He specifically pointed to sections such as 301, 232, and 122 as mechanisms through which the existing tariff framework could be replicated and sustained. Bessent clarified that while some measures, like those under section 122, are inherently permanent, others could be made so through strategic application.

He contended that any unfavorable ruling from the Supreme Court would primarily impact the American populace rather than the administration's resolve. Bessent framed tariffs as a transitional measure, with the overarching aim of rebalancing international trade and fostering domestic manufacturing. Despite the legal uncertainties, he maintained an optimistic outlook on the Supreme Court's eventual ruling.

The Treasury Secretary also highlighted perceived achievements, particularly in U.S.-China trade relations. He credited the imposition of fentanyl-related tariffs for spurring China to take decisive action against the drug's illicit entry into the U.S. This outcome, he suggested, demonstrates the effectiveness of the administration's tariff strategy. Bessent also addressed a recent lawsuit filed by Costco Wholesale against the Trump administration, seeking a full refund of tariffs, rhetorically questioning the legitimacy of such a claim.

Echoing Bessent's perspective, Chief Equity Strategist Jeff Buchbinder previously noted that even in the event of an adverse Supreme Court decision, the administration possesses alternative legal avenues to reinstate tariffs. A likely approach could involve utilizing Section 122 to implement temporary 150-day tariffs, linked to significant trade deficits. This would provide the U.S. Trade Representative with time to conduct necessary investigations, paving the way for more enduring Section 301 tariffs targeting unfair trade practices.

In October, former President Donald Trump voiced concerns that a Supreme Court decision striking down the tariffs could lead to prolonged economic struggles for the U.S. Conversely, economists like Peter Schiff have speculated that such a ruling might offer President Trump a convenient explanation for any subsequent economic downturns. It is noteworthy that the Supreme Court has already expressed reservations about the legality of the tariffs, with justices questioning the president's broad authority under the 1977 International Emergency Economic Powers Act (IEEPA).

In summary, Treasury Secretary Scott Bessent remains steadfast in the administration's commitment to its tariff policies. He believes that even with potential Supreme Court challenges, legal frameworks exist to ensure the continuity of these trade measures. The focus remains on leveraging tariffs as a tool to rebalance global trade and support domestic production, a strategy he views as successful, particularly in engaging with China.

UiPath Shares Surge, Leading Premarket Movers

UiPath Inc. experienced a notable increase in its stock value during pre-market trading, propelled by impressive third-quarter financial outcomes and an encouraging sales outlook for the upcoming quarter. This upward trend placed UiPath prominently among a diverse group of companies witnessing significant movements before the official market open.

Detailed Report on Morning Market Activity

On December 4, 2025, UiPath Inc. (NYSE: PATH) recorded a substantial rise in its shares during pre-market trading, climbing approximately 9%. This surge was primarily driven by the company's robust third-quarter performance, which revealed an adjusted earnings per share of 16 cents, surpassing the Street's projection of 15 cents. Furthermore, quarterly revenue reached $411.11 million, comfortably exceeding the consensus estimate of $392.97 million and marking a considerable increase from the $354.65 million reported in the same period last year. The company also provided an optimistic sales guidance for the fourth quarter, with its midpoint exceeding analyst expectations. At the close of pre-market trading, UiPath shares stood at $16.18.

Beyond UiPath, several other companies demonstrated significant shifts in their stock prices:

Notable Gainers Included:

  • Polyrizon Ltd. (NASDAQ: PLRZ) saw an extraordinary jump of 158.1% to $18.30. This impressive rise followed the announcement of preclinical data indicating that its proprietary naloxone hydrogel demonstrated superior nasal tissue adherence compared to an existing intranasal naloxone spray.
  • Nauticus Robotics, Inc. (NASDAQ: KITT) surged by 34% to $2.09 amidst reports of Commerce Secretary Howard Lutnick's discussions with robotics industry leaders to foster sector growth.
  • Picard Medical, Inc. (NYSE: PMI) increased by 22.3% to $2.47.
  • Meiwu Technology Company Limited (NASDAQ: WNW) advanced by 20.9% to $1.68 after signing a Memorandum of Understanding with Real BioTech (Qingdao) Ltd.
  • Universe Pharmaceuticals INC (NASDAQ: UPC) climbed 19.5% to $4.22.
  • Hyster-Yale, Inc. (NYSE: HY) rose by 13.6% to $39.03, extending gains from the previous day.
  • KALA BIO, Inc. (NASDAQ: KALA) experienced a 13.5% increase to $1.05 following Securities and Exchange Commission filings that indicated Oxford Finance LLC's acquisition of 1.62 million common shares, representing a 16.5% ownership stake.
  • Axogen, Inc. (NASDAQ: AXGN) gained 11% to $31.43 after receiving FDA approval for its Biologics License Application for AVANCE® (acellular nerve allograft–arwx).
  • Anbio Biotechnology (NASDAQ: NNNN) jumped 9.7% to $37.88, building on a 25% gain from the prior day.

Significant Losers Included:

  • Virax Biolabs Group Ltd (NASDAQ: VRAX) declined 16.2% to $0.58, attributed to definitive agreements to sell 12.5 million ordinary shares at $0.40 per share in a private placement.
  • Treasure Global Inc (NASDAQ: TGL) fell 13.3% to $0.26, following an announcement of a 1-for-20 reverse stock split and a Nasdaq delisting notification.
  • Net Lease Office Properties (NYSE: NLOP) decreased 14.7% to $25.19.
  • Addex Therapeutics Ltd – ADR (NASDAQ: ADXN) dipped 11.4% to $7.84 after reporting a third-quarter loss of $1.50 per share.
  • Vicarious Surgical Inc (NYSE: RBOT) shares dropped 11.1% to $2.93, despite a 27% gain on Wednesday, as the company lowered its full-year 2025 cash burn outlook.
  • Symbotic Inc (NASDAQ: SYM) fell 10.5% to $65.50 after announcing a 10 million share offering.
  • Immuron Ltd – ADR (NASDAQ: IMRN) saw a 9.1% drop to $1.41, extending its Wednesday losses.
  • Snowflake Inc (NYSE: SNOW) declined 8.6% to $241.85 after its quarterly results.
  • Capricor Therapeutics Inc (NASDAQ: CAPR) dipped 8.4% to $27.45. This came after a massive 371% surge on Wednesday, following positive topline results from its Phase 3 HOPE-3 Trial for Duchenne Muscular Dystrophy.
  • Koninklijke Philips NV (NYSE: PHG) fell 6.8% to $26.11.

This dynamic pre-market activity highlights the critical role of financial reports, strategic announcements, and broader market sentiment in shaping investor confidence and immediate stock valuations. For investors, these early movements can signal underlying trends and potential opportunities or risks as the trading day unfolds.

See More

OpenAI's Sam Altman Explores Space Industry Expansion with Potential Acquisition of SpaceX Rival

OpenAI's CEO, Sam Altman, recently explored a significant venture into the space industry, reportedly considering an acquisition or partnership with Stoke Space. This move reflects a broader strategic realignment within OpenAI, highlighted by an internal 'code red' initiative focused on enhancing the quality of its offerings. The potential deal would have positioned Altman and OpenAI within the burgeoning sector of commercial space flight, directly engaging with a company seen as a rival to Elon Musk's established SpaceX.

The negotiations centered on Stoke Space, an innovative enterprise established by former personnel from Jeff Bezos's Blue Origin. Based in Kent, Washington, Stoke Space has garnered attention for its ambition to revolutionize access to space, emphasizing 'seamless mobility to, through, and from space.' Their flagship product, the Nova rocket, is touted for its complete reusability and a sophisticated liquid, regeneratively cooled metallic reentry heat shield. This technology underscores a commitment to sustainable and efficient space operations, capable of delivering a substantial payload of three tons to Low Earth Orbit.

Reports suggest that Altman's interest in Stoke Space extended to seeking a controlling equity stake, indicating a desire for significant influence over the company's direction. However, the discussions ultimately did not materialize into a definitive agreement and were concluded earlier in the year. This exploration by a leading AI figure into the space domain highlights the increasing convergence of cutting-edge technologies and industries.

The broader context for Altman's interest lies in the growing trend among tech giants to establish orbital data centers. Visionaries like Elon Musk have been vocal about the potential of solar-powered AI satellites, predicting a future where his diverse ventures—Tesla, SpaceX, and xAI—converge to leverage space-based infrastructure. Musk views these orbital data centers as a cost-effective alternative to terrestrial facilities, with chip production remaining the primary hurdle.

Similarly, Amazon founder Jeff Bezos has championed the concept of Gigawatt-scale orbital data centers, foreseeing their realization within the next decade or two. Bezos, through initiatives like 'Project Prometheus,' is also investing in AI applications across various sectors, including aerospace. Not to be outdone, Alphabet CEO Sundar Pichai has unveiled 'Project Suncatcher,' an ambitious plan to launch Google's AI data centers into low Earth orbit, powered directly by solar energy, further illustrating the industry-wide pivot towards extraterrestrial data solutions.

The reported endeavors by Sam Altman to enter the space sector, alongside the established efforts of Musk, Bezos, and Pichai, underscore a transformative period where the frontiers of artificial intelligence and space technology are rapidly expanding. This convergence promises to reshape industries, offering innovative solutions for data management and global connectivity, pushing the boundaries of what is technologically feasible.

See More